Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.
Chang later returned home on the same road where hours earlier he’d hit Lilly Glaubach. He spent one more night with his wife and daughter before police knocked on his door after a Good ...
A small Swiss biotech has terminated a mid-stage test of a new type of oral drug for people with Alzheimer’s disease, according to the federal … ...
Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...
One of the world’s largest hornet species appears to have quite a diverse palate. When studying the Asian hornets’ (Vespa velutina) gut contents, a team of researchers from the University of ...
Capcom has revealed that its smash hit Monster Hunter Wilds has a game-breaking bug late in the campaign that can make further story progress impossible. The bug occurs in chapter 5-2: A World ...
Red bugs have appeared in large swarms across large parts of South Australia, including around Adelaide and in the Riverland. Identifying the insect species has been a challenge, but entomologists ...
To enquire about specific property features for 64 Lilly Pilly Court, Burpengary, contact the agent. What is the size of the property at 64 Lilly Pilly Court, Burpengary? The external land size ...
Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...
Capcom confirms hotfix release for Monster Hunter Wilds that addresses a game-breaking campaign bug. The update also addresses issues with Ingredient Center and Grill a Meal. After the hotfix is ...
Credit: shisu_ka/Shutterstock. Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The ...
Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback